JPRN-UMIN000014355Completed未知
ncontrolled trial of Rituximab treatment on refractory or steroid dependent nephrotic syndrome in adult. - Uncontrolled trial of Rituximab treatment on refractory or steroid dependent nephrotic syndrome in adult.
Saitama Medical University Department of Nephrology0 sites5 target enrollmentStarted: July 1, 2014Last updated:
Conditions
Trial Snapshot
- Phase
- 未知
- Status
- Completed
- Sponsor
- Enrollment
- 5
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 20years-old to ot applicable (—)
- Sex
- All
Inclusion Criteria
- Not provided
Exclusion Criteria
- •Positive serology for hepatitis B, Cardiac failure, Lung dysfunction, Bone marrow dysfunction, Pregnant subjects or subjects who do not agree with contraception during the study period
Investigators
Similar Trials
Active, not recruiting
Not Applicable
A Randomized Controlled Trial of Rituximab Versus Steroids and Cyclophosphamide in the Treatment of Idiopathic Membranous Nephropathy (IMN)MN is an autoimmune disease, suggesting that the disease may be triggered by isotype specific autoantibodies directed against podocyte enzymes and podocyte receptors that are recognized as antigens. The key role of IgG antibodies formation in the pathogenesis of IMN suggests that B cell depletion may favourably impact the evolution of the glomerular disease and reduce proteinuria. We propose this study in order to test in a randomized controlled trial the hypMedDRA version: 14.1Level: PTClassification code 10018372Term: Glomerulonephritis membranousSystem Organ Class: 10038359 - Renal and urinary disordersEUCTR2011-006115-59-ITAZIENDA OSPEDALIERA SPEDALI CIVILI DI BRESCIA
Active, not recruiting
Not Applicable
Pilot study to evaluate the effect of Rituximab in combination with MTX in the inhibition of progression of synovitis, bone marrow edema, and erosions evaluated by magnetic resonance imaging (MRI) in the hand of patients with rheumatoid arthritis. - NDMedDRA version: 9.1Level: LLTClassification code 10039073Term: Rheumatoid arthritisRheumatoid arthritisEUCTR2007-001754-11-ITROCHE
Active, not recruiting
Not Applicable
A randomized trial of Rituximab in induction therapy for living donor renal transplantation - Randomized trial of rituximab in renal transplantatioEnd stage renal diseaserenal function after renal transplantationMedDRA version: 17.0Level: PTClassification code 10038533Term: Renal transplantSystem Organ Class: 10042613 - Surgical and medical proceduresEUCTR2009-017066-23-GBGuys and St Thomas Foundation Trust
Active, not recruiting
Phase 1
A multi-centre pilot study of Rituximab in patients with active PsAPsoriatic ArthritisEUCTR2006-000844-17-SKVienna Medical University30
Recruiting
Not Applicable
Clinical trial of Rituximab for desensitization or antibody mediated rejection therapy in anti-donor HLA antibody positive patientsChronic renal dysfunction or post kidney transplant recipientsJPRN-jRCTs031180323Saito Kazuhide20